Streetbeat News

Analyst Ratings

RXRX

Needham analyst Gil Blum has reiterated a 'Buy' rating on Recursion Pharmaceuticals (NASDAQ:RXRX) and maintained a price target of $17.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 8:06 am

PAYO

Needham analyst Mayank Tandon has reiterated a 'Buy' rating on Payoneer Global (NASDAQ:PAYO) and maintained a price target of $10.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 8:05 am

BRBR

Needham analyst Matt McGinley has reiterated a 'Buy' rating on BellRing Brands (NYSE:BRBR) and maintained a price target of $44.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 7:55 am

CECO

Needham analyst James Ricchiuti has reiterated a 'Buy' rating on CECO Environmental (NASDAQ:CECO) and maintained a price target of $17.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 7:54 am

COGT

Needham analyst Ami Fadia has reiterated a 'Buy' rating on Cogent Biosciences (NASDAQ:COGT) and maintained a price target of $22.

Portfolio Pulse from richadhand@benzinga.com

August 09, 2023 | 7:53 am

WEN

The Wendy's Company (NASDAQ:WEN) is expected to report higher Q2 2023 earnings of 27 cents per share, up from 24 cents per share in the previous year. The company's revenue is projected to be $566.95 million, up from $537.78 million in the year-ago period. Wendy's shares fell 0.5% to close at $21.73 on Tuesday. Several analysts have recently adjusted their price targets for the company, with ratings ranging from Neutral to Overweight.

Portfolio Pulse from Lisa Levin

August 09, 2023 | 7:37 am

ICL

ICL Group reported Q2 earnings of $0.13 per share, beating the analyst consensus estimate of $0.12 by 8.33%. However, this is a 77.59% decrease from the same period last year. The company's quarterly sales of $1.83 billion missed the analyst consensus estimate of $2.02 billion by 9.41%, marking a 36.46% decrease from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 09, 2023 | 6:49 am

ARKF

ARKK

ARKW

DKNG

PACB

PLTR

ROKU

Ark Invest, led by Cathie Wood, purchased nearly $14 million worth of shares in Palantir Technologies Inc (NYSE:PLTR) following the company's Q2 earnings report. The purchase was made through ARK Innovation ETF (NYSE:ARKK), ARK Next Generation Internet ETF (NYSE:ARKW), and Ark Fintech Innovation ETF (NYSE:ARKF). Ark Invest also bought shares of Pacific Biosciences Of California (NASDAQ:PACB) and sold shares of DraftKings Inc (NASDAQ:DKNG) and Roku Inc (NASDAQ:ROKU).

Portfolio Pulse from Benzinga Neuro

August 09, 2023 | 3:03 am

BTCUSD

DOGEUSD

ETHUSD

Major cryptocurrencies including Bitcoin, Ethereum, and Dogecoin saw significant gains on Tuesday amid optimism about the prospects of a spot Bitcoin ETF being approved by the SEC. Ark Invest CEO Cathie Wood and Galaxy Digital CEO Mike Novogratz expressed their optimism about the ETF. PayPal is set to launch a stablecoin tied to the U.S. dollar. The global crypto market capitalization stands at $1.19 trillion, a 2.11% increase in the last day. Stocks declined on Tuesday as the banking sector received a downgrade from Moody's.

Portfolio Pulse from Mehab Qureshi

August 09, 2023 | 2:40 am

UBX

Unity Biotechnology reported Q2 losses of $(0.85) per share, beating the analyst consensus estimate of $(0.86) by 1.16 percent. This represents a 55.26 percent increase over losses of $(1.90) per share from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 08, 2023 | 10:08 pm